Alzheimer'S Disease Clinical Trials in Columbia, SC

Alzheimer'S Disease Clinical Trials in Columbia, SC

View the best 10 alzheimer's disease medical studies in Columbia, South Carolina. Access promising new therapies by applying to a Columbia-based Alzheimer'S Disease clinical trial.

Trials in Columbia, South Carolina

Here are the top 8 medical studies for alzheimer's disease in Columbia, South Carolina

Image of Barrow Neurological Institute in Phoenix, United States.

Sensory Stimulation System (GS120)

Behavioural Intervention

Recruiting1 award
This trial is an extension of a previous study where participants will receive treatment with an Active Sensory Stimulation System for up to 12 months. There will be no sham treatment or randomization in this
Image of Clinical Trial Site in Chandler, United States.

KarXT

Behavioural Intervention

Recruiting1 awardPhase 3
This trial is testing KarXT, a medication for adults aged 55-90 with Alzheimer's Disease and severe psychosis. The goal is to see if KarXT can reduce symptoms like hallucinations and delusions by balancing brain chemicals.
Image of Clinical Research Site in Birmingham, United States.

AVP-786

Behavioural Intervention

Recruiting1 awardPhase 3
This trial tests a combination of two drugs taken by mouth to help calm severe agitation in people with Alzheimer's disease by balancing brain chemicals.
Image of Location - 001 in Princeton, United States.

KarXT

Behavioural Intervention

Recruiting1 awardPhase 3
This trial aims to test the safety and effectiveness of KarXT in adults with Alzheimer's Disease who also have psychosis.
Image of Linfritz Research Institute Inc. in Coral Gables, United States.

Placebo +1 More

Recruiting0 awardsPhase 2 & 3
This trial tests piromelatine, a pill taken before bed, in people with mild Alzheimer's who lack a specific genetic variation. The goal is to see if it can improve brain function and slow down dementia progression.
Image of Clinical Research Site in Peoria, United States.

AXS-05

Behavioural Intervention

Recruiting2 awardsPhase 3
This trial will assess the safety of AXS-05 over a long period for treating agitation in Alzheimer's patients who were in two previous studies.
Image of Noah Clinical Site 017 in Scottsdale, United States.

Polypill

Fixed Dose Combination

Recruiting0 awardsPhase 2
This trial aims to see how well a combination drug called a polypill works for patients with Alzheimer's Disease over 180 days. They will include male and female patients aged 50-85 with
Image of ARS- Neurology and Neurodiagnostics of Alabama in Hoover, United States.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing donanemab, a drug for early Alzheimer's disease. It targets people with early symptoms and specific brain changes. The drug helps remove harmful proteins from the brain, potentially slowing down or improving symptoms.

Phase 3 Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.